📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
40
Warrant Exposure
40
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market CapN/A
Shares OutstandingN/A
FloatN/A
Cash$1.16M
Debt$564.47M
Short InterestN/A
🏛 Institutional Holdings
17.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest618.3K
Days to Cover1.1
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for GAIN
📊 GAIN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GAIN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.